Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 13, 2018

SELL
$29.25 - $36.73 $2.63 Million - $3.31 Million
-90,000 Closed
0 $0
Q2 2018

Aug 06, 2018

BUY
$28.49 - $35.06 $976,836 - $1.2 Million
34,287 Added 61.54%
90,000 $2.9 Million
Q1 2018

May 08, 2018

SELL
$31.93 - $39.54 $615,833 - $762,607
-19,287 Reduced 25.72%
55,713 $1.82 Million
Q4 2017

Feb 08, 2018

BUY
$34.15 - $37.62 $853,750 - $940,499
25,000 Added 50.0%
75,000 $2.82 Million
Q3 2017

Nov 08, 2017

BUY
$30.11 - $37.72 $1.51 Million - $1.89 Million
50,000
50,000 $1.78 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.56B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Sivik Global Healthcare LLC Portfolio

Follow Sivik Global Healthcare LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.